BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7124857)

  • 21. Alternative data sources and discrepant results in case-control studies of estrogens and endometrial cancer.
    Horwitz RI; Feinstein AR; Stremlau JR
    Am J Epidemiol; 1980 Apr; 111(4):389-94. PubMed ID: 7377181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholecystectomy and endometrial cancer: a marker of long-term elevated estrogen exposure?
    Morimoto LM; Newcomb PA; Hampton JM; Trentham-Dietz A
    Int J Gynecol Cancer; 2006; 16(3):1348-53. PubMed ID: 16803528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen and endometrial cancer: cases and two control groups from North Carolina.
    Hulka BS; Fowler WC; Kaufman DG; Grimson RC; Greenberg BG; Hogue CJ; Berger GS; Pulliam CC
    Am J Obstet Gynecol; 1980 May; 137(1):92-101. PubMed ID: 6245580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of exogenous estrogen therapy and endometrial cancer.
    Jelovsek FR; Hammond CB; Woodard BH; Draffin R; Lee KL; Creasman WT; Parker RT
    Am J Obstet Gynecol; 1980 May; 137(1):85-91. PubMed ID: 7369293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noncontraceptive estrogens and abnormalities of endometrial proliferation.
    Weiss NS
    Ann Intern Med; 1978 Mar; 88(3):410-2. PubMed ID: 629503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus.
    Schwartz SM; Weiss NS; Daling JR; Gammon MD; Liff JM; Watt J; Lynch CF; Newcomb PA; Armstrong BK; Thompson WD
    Cancer; 1996 Feb; 77(4):717-24. PubMed ID: 8616764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case-control study of cancer of the endometrium.
    Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Mostow ED; Schwartz PE; O'Connor T; White C
    Am J Epidemiol; 1982 Aug; 116(2):333-42. PubMed ID: 7114042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous estrogens and endometrial cancer.
    Gordan GS; Greenberg BG
    Postgrad Med; 1976 Jun; 59(6):66-77. PubMed ID: 778818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oestrogen replacement and endometrial cancer. A statement by the British Gynaecological Cancer Group.
    Lancet; 1981 Jun; 1(8234):1359-60. PubMed ID: 6113323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current views on the epidemiology and etiology of endometrial carcinoma].
    Kaiser R; Schulz KD
    Gynakologe; 1983 Jun; 16(2):82-6. PubMed ID: 6350118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of exogenous estrogen and endometrial carcinoma.
    Smith DC; Prentice R; Thompson DJ; Herrmann WL
    N Engl J Med; 1975 Dec; 293(23):1164-7. PubMed ID: 1186789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The joint effect of risk factors on endometrial cancer.
    Ewertz M; Schou G; Boice JD
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):189-94. PubMed ID: 3356205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing trends and prognostic features in endometrial cancer associated with exogenous estrogen therapy.
    Robboy SJ; Bradley R
    Obstet Gynecol; 1979 Sep; 54(3):269-77. PubMed ID: 471366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogens and endometrial carcinoma.
    Gray LA; Christopherson WM; Hoover RN
    Obstet Gynecol; 1977 Apr; 49(4):385-9. PubMed ID: 193072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
    Brinton LA; Hoover RN
    Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of epidemiologic studies of endometrial cancer and exogenous estrogen.
    Cramer DW; Knapp RC
    Obstet Gynecol; 1979 Oct; 54(4):521-6. PubMed ID: 492641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum androgens and estrogens in postmenopausal women with and without endometrial cancer.
    Judd HL; Davidson BJ; Frumar AM; Shamonki IM; Lagasse LD; Ballon SC
    Am J Obstet Gynecol; 1980 Apr; 136(7):859-71. PubMed ID: 7361834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival among women with endometrial cancer: a comparison of estrogen users and nonusers.
    Chu J; Schweid AI; Weiss NS
    Am J Obstet Gynecol; 1982 Jul; 143(5):569-73. PubMed ID: 7091228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of estrogen use by women with endometrial cancer, gynecologic disorders, and other illnesses.
    Stavraky KM; Collins JA; Donner A; Wells GA
    Am J Obstet Gynecol; 1981 Nov; 141(5):547-55. PubMed ID: 7294081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.